Exploration of therapeutic role of montelukast and dexamethasone combination against paraquat induced inhalational toxicity.
Conclusions: Given the advantage of therapeutic synergism activity of MON and DXM, it may be used in the prophylaxis of PQ-intoxication following clinical trials.
PMID: 32597253 [PubMed - as supplied by publisher]
Source: Inhalation Toxicology - Category: Respiratory Medicine Tags: Inhal Toxicol Source Type: research
More News: Antidoxidants | Clinical Trials | Dexamethasone | Respiratory Medicine | Study | Toxicology